Clinical application of hepatitis C virus core protein in early diagnosis of acute hepatitis C

Journal of Gastroenterology

Volumn 33, Issue 4, 1998, Pages 508-511

  Kobayashi, Masakazu ^a   Tanaka, Eiji ^a   Matsumoto, Akihiro ^a   Yoshizawa, Kaname ^a   Imai, Haruhiko ^a   Sodeyama, Takeshi ^a   Kiyosawa, Kendo ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

FEIA; HCV antibody; HCV RNA; Post transfusion hepatitis

Indexed keywords

CORE PROTEIN; HEPATITIS C ANTIBODY; VIRUS PROTEIN; VIRUS RNA;

ACUTE HEPATITIS; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DIAGNOSTIC VALUE; DISEASE COURSE; EARLY DIAGNOSIS; ENZYME IMMUNOASSAY; FEMALE; FLUORESCENCE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MALE; PRIORITY JOURNAL;

ACUTE DISEASE; ADULT; BIOLOGICAL MARKERS; BLOOD TRANSFUSION; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; VIRAL CORE PROTEINS;

EID: 0031868491     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350050123     Document Type: Article

References (17)

1. Choo Q-L, Kuo G, Weiner AJ, et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989;244:1-3.
2. Kuo G, Choo Q-L, Alter HJ, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989;244:362-364.
3. Aach RD, Stevens CE, Hollinger FB, et al. Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first-and second-generation assays. N Engl J Med 1991;325:1325-1329.
4. Huber KR, Sebesta C, Bauer K, et al. Detection of common hepatitis C virus subtypes with a third-generation enzyme immunoassay. Hepatology 1996;24:471-473.
5. Alter HJ, Purcell RH, Shih JW, et al. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A non-B hepatitis. N Engl J Med 1993;321:1494-1500.
6. Barrera JM, Bruguera M, Ercilla MG, et al. Persistent hepatitis C viremia after acute self-limiting posttransfusion hepatitis C. Hepatology 1995;21:639-644.
7. Nakatsuji Y, Matsumoto A, Tanaka E, et al. Detection of chronic hepatitis C virus infection by four diagnostic systems: First-generation and second-generation enzyme-linked immunosorbent assay, second-generation recombinant immunoblot assay and nested polymerase chain reaction analysis. Hepatology 1992; 16:300-305.
8. Lau JY, Davis GL, Kniffen J, et al. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 1993;341:1501-1504.
9. Kashiwakuma T, Hasegawa A, Kajita T, et al. Detection of hepatitis C virus specific core protein in serum of patients by a sensitive fluorescence enzyme immunoassay (FEIA). J Immunol Methods 1996;190:79-89.
10. Tanaka T, Lau JYN, Mizokami M, et al. Simple fluorescent enzyme immunoassay for detection and quantification of hepatitis C viremia. J Hepatol 1995;23:742-745.
11. Tanaka E, Kiyosawa K, Matsumoto A, et al. Serum levels of hepatitis C virus core protein in patients with chronic hepatitis C treated with interferon alfa. Hepatology 1996;23:1330-1333.
12. Orito E, Mizokami M, Tanaka T, et al. Quantification of serum hepatitis C virus core protein level in patients chronically infected with different hepatitis C virus genotypes. Gut 1996;39:876-880.
13. Decker RH, Kosakowski SM, Vanderbilt AS, et al. Diagnosis of acute hepatitis A by HAVAB-M, a direct radioimmunoassay for IgM anti-HAV. Am J Clin Pathol 1981;76:140-147.
14. Shimizu M, Ohyama M, Takahashi Y, et al. Immunoglobulin M antibody against hepatitis B core antigen for the diagnosis of fulminant type B hepatitis. Gastroenterology 1983;84:604-610.
15. Quiroga JA, Campillo ML, Catillo I, et al. IgM antibody to hepatitis C virus in acute and chronic hepatitis C. Hepatology 1991;14:38-43.
16. Nagayama R, Miyake K, Tsuda F, et al. IgM antibody to a hepatitis C virus core peptide (CP14) for monitoring activity of liver disease in patients with acute or chronic hepatitis C. J Med Virol 1994;42:311-317.
17. Matsumoto A, Tanaka E, Suzuki T, et al. Viral and host factors that contribute to efficacy of interferon a theraoy in patients with chronic hepatitis C. Dig Dis Sci 1994;39:1273-1280.